Advertisement

Hodgkin Lymphoma

A Comprehensive Overview

  • Andreas Engert
  • Anas Younes

Part of the Hematologic Malignancies book series (HEMATOLOGIC)

Table of contents

  1. Front Matter
    Pages i-xv
  2. Epidemiology and Pathogenesis

    1. Front Matter
      Pages 1-1
    2. Sally L. Glaser, Ellen T. Chang, Christina A. Clarke, Theresa H. Keegan
      Pages 3-26
    3. Andreas Rosenwald, Ralf Küppers
      Pages 45-64
    4. Lydia Visser, Anke van den Berg, Sibrand Poppema, Arjan Diepstra
      Pages 65-78
    5. Christian Steidl, Randy D. Gascoyne
      Pages 79-92
  3. Diagnosis and First-Line Treatment

    1. Front Matter
      Pages 93-93
    2. Jim Armitage, Christian Gisselbrecht
      Pages 95-106
    3. Andrea Gallamini, Martin Hutchings, Anna Borra
      Pages 107-130
    4. Lena Specht, Dirk Hasenclever
      Pages 131-155
    5. Joachim Yahalom, Richard T. Hoppe
      Pages 157-176
    6. Peter Johnson, David Straus
      Pages 177-199
    7. Pieternella Lugtenburg, Anton Hagenbeek
      Pages 201-220
    8. John M. M. Raemaekers, Andreas Engert
      Pages 221-234
    9. Peter Borchmann, Massimo Federico, Volker Diehl
      Pages 235-250
  4. Special Clinical Situations

    1. Front Matter
      Pages 251-251
    2. Georgina W. Hall, Cindy L. Schwartz, Stephen Daw, Louis S. Constine
      Pages 253-270
    3. Boris Böll, Andrew M. Evens
      Pages 271-286
    4. Dennis A. Eichenauer, Michelle A. Fanale
      Pages 287-295
    5. Veronika Bachanova, Joseph M. Connors
      Pages 297-305
    6. Michele Spina, Marcus Hentrich, Umberto Tirelli
      Pages 307-318
  5. Relapsed and Refractory Disease

    1. Front Matter
      Pages 319-319
    2. Bastian von Tresckow, Craig Moskowitz
      Pages 321-330
    3. Anna Sureda, Stephen Mackinnon
      Pages 331-341
    4. Anita Kumar, Stefano Pileri, Anas Younes, Andreas Engert
      Pages 343-354
    5. Alison J. Moskowitz, Anas Younes
      Pages 355-361
  6. Survivorship

    1. Front Matter
      Pages 363-363
    2. Teresa V. Halbsguth, Hans-Henning Flechtner
      Pages 365-374
    3. David C. Hodgson, Flora E. van Leeuwen
      Pages 375-409
    4. Berthe M. P. Aleman, David J. Cutter
      Pages 411-425
    5. Karolin Behringer, Michael von Wolff
      Pages 427-437

About this book

Introduction

This book examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the management appropriate in special clinical circumstances, including in the elderly, pregnant women, and those with lymphocyte-predominant disease. Careful attention is devoted to the emerging individually tailored treatment strategies that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The second edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by the key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.

.

Keywords

CD30 Combined modality treatment Late effects Microenvironment PET

Editors and affiliations

  • Andreas Engert
    • 1
  • Anas Younes
    • 2
  1. 1.Universitätsklinikum Köln Klinik I für Innere MedizinKölnGermany
  2. 2.Memorial Sloan - Kettering Cancer CenterNew YorkUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-12505-3
  • Copyright Information Springer International Publishing 2015
  • Publisher Name Springer, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-12504-6
  • Online ISBN 978-3-319-12505-3
  • Series Print ISSN 2197-9766
  • Series Online ISSN 2197-9774
  • Buy this book on publisher's site